162 related articles for article (PubMed ID: 15305187)
1. Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
Franceschi E; Cavallo G; Scopece L; Paioli A; Pession A; Magrini E; Conforti R; Palmerini E; Bartolini S; Rimondini S; Esposti RD; Crinò L
Br J Cancer; 2004 Sep; 91(6):1038-44. PubMed ID: 15305187
[TBL] [Abstract][Full Text] [Related]
2. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
Scopece L; Franceschi E; Cavallo G; Paioli A; Paioli G; Conforti R; Palmerini E; Berzioli C; Spagnolli F; Esposti RD; Crinò L
J Neurooncol; 2006 Sep; 79(3):299-305. PubMed ID: 16645720
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
Schäfer N; Tichy J; Thanendrarajan S; Kim Y; Stuplich M; Mack F; Rieger J; Simon M; Scheffler B; Boström J; Steinbach JP; Herrlinger U; Glas M
Oncology; 2011; 80(5-6):330-2. PubMed ID: 21791942
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
Robins HI; Chang SM; Prados MD; Yung WK; Hess K; Schiff D; Greenberg H; Fink K; Nicolas K; Kuhn JG; Cloughesy T; Junck L; Mehta M
Neuro Oncol; 2002 Apr; 4(2):109-14. PubMed ID: 11916502
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.
Rossman J; Reddy V; Cantor A; Miley D; Robert F
Lung Cancer; 2011 May; 72(2):219-23. PubMed ID: 20934233
[TBL] [Abstract][Full Text] [Related]
8. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
Radiother Oncol; 1999 Apr; 51(1):27-33. PubMed ID: 10386714
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
Galanis E; Buckner JC; Maurer MJ; Reid JM; Kuffel MJ; Ames MM; Scheithauer BW; Hammack JE; Pipoly G; Kuross SA
Invest New Drugs; 2005 Oct; 23(5):495-503. PubMed ID: 16133802
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.
Tonder M; Weller M; Eisele G; Roth P
Chemotherapy; 2014; 60(5-6):375-8. PubMed ID: 26496463
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
[TBL] [Abstract][Full Text] [Related]
12. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Gnekow AK; Walker DA; Kandels D; Picton S; Giorgio Perilongo ; Grill J; Stokland T; Sandstrom PE; Warmuth-Metz M; Pietsch T; Giangaspero F; Schmidt R; Faldum A; Kilmartin D; De Paoli A; De Salvo GL;
Eur J Cancer; 2017 Aug; 81():206-225. PubMed ID: 28649001
[TBL] [Abstract][Full Text] [Related]
13. Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.
López-Aguilar E; Sepúlveda-Vildósola AC; Rivera-Márquez H; Cerecedo-Díaz F; Hernández-Contreras I; Ramón-García G; Diegopérez-Ramírez J; Santacruz-Castillo E
Arch Med Res; 2000; 31(2):186-90. PubMed ID: 10880725
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
Williams PC; Henner WD; Roman-Goldstein S; Dahlborg SA; Brummett RE; Tableman M; Dana BW; Neuwelt EA
Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
Aoki T; Mizutani T; Nojima K; Takagi T; Okumura R; Yuba Y; Ueba T; Takahashi JA; Miyatake S; Nozaki K; Taki W; Matsutani M
J Neurosurg; 2010 Jan; 112(1):50-6. PubMed ID: 19538050
[TBL] [Abstract][Full Text] [Related]
17. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
[TBL] [Abstract][Full Text] [Related]
18. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
Jeremic B; Grujicic D; Jevremovic S; Stanisavljevic B; Milojevic L; Djuric L; Mijatovic L
J Clin Oncol; 1992 Jul; 10(7):1074-7. PubMed ID: 1318951
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
Sanson M; Ameri A; Monjour A; Sahmoud T; Ronchin P; Poisson M; Delattre JY
Eur J Cancer; 1996 Dec; 32A(13):2229-35. PubMed ID: 9038603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
